Regular Article

British Journal of Cancer (2001) 85, 297–302. doi:10.1054/bjoc.2001.1879 www.bjcancer.com
Published online 17 July 2001

Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)

M J Lorite1, H J Smith1, J A Arnold1, A Morris2, M G Thompson2 and M J Tisdale1

  1. 1Pharmaceutical Sciences Research Institute, Aston University, Birmingham, B4 7ET, UK
  2. 2Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen, AB21 9SB, UK

Received 23 January 2001; Revised 30 March 2001; Accepted 2 April 2001.

Top

Abstract

Loss of skeletal muscle is a major factor in the poor survival of patients with cancer cachexia. This study examines the mechanism of catabolism of skeletal muscle by a tumour product, proteolysis-inducing factor (PIF). Intravenous administration of PIF to normal mice produced a rapid decrease in body weight (1.55 plusminus 0.12 g in 24 h) that was accompanied by increased mRNA levels for ubiquitin, the Mr 14 000 ubiquitin carrier-protein, E2, and the C9 proteasome subunit in gastrocnemius muscle. There was also increased protein levels of the 20S proteasome core and 19S regulatory subunit, detectable by immunoblotting, suggesting activation of the ATP-ubiquitin-dependent proteolytic pathway. An increased protein catabolism was also seen in C2C12myoblasts within 24 h of PIF addition with a bell-shaped dose–response curve and a maximal effect at 2–4 nM. The enhanced protein degradation was attenuated by anti-PIF antibody and by the proteasome inhibitors MG115 and lactacystin. Glycerol gradient analysis of proteasomes from PIF-treated cells showed an elevation in chymotrypsin-like activity, while Western analysis showed a dose-related increase in expression of MSSI, an ATPase that is a regulatory subunit of the proteasome, with a dose–response curve similar to that for protein degradation. These results confirm that PIF acts directly to stimulate the proteasome pathway in muscle cells and may play a pivotal role in protein catabolism in cancer cachexia. © 2001 Cancer Research Campaign www.bjcancer.com

Keywords:

cachexia, muscle proteolysis, proteolysis- inducing factor (PIF), ubiquitin-proteasome proteolysis

Top

References

  1. Attaix P and Taillander D (1998) The critical role of the ubiquitin-proteasome pathway in muscle wasting in comparison to lysosomal and Ca2+-dependent systems. Adv Mol Cell Biol 27: 235–266
  2. Beck SA and Tisdale MJ (1987) Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res 47: 5919–5923 | PubMed | ISI | ChemPort |
  3. Cariuk P, Lorite MJ, Todorov PT, Field WN, Wigmore SJ and Tisdale MJ (1997) Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients. Br J Cancer 76: 606–613 | PubMed | ISI | ChemPort |
  4. Chomczynski P and Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159 | Article | PubMed | ISI | ChemPort |
  5. Dardevet D, Sornet C, Taillandier D, Savary I, Attaix D and Grizard J (1995) Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome pathway in aging. J Clin Invest 96: 2113–2119
  6. Dawson SP, Arnold JE, Mayer NJ, Reynolds SE, Billet MA, Gordan C, Collenux L, Kloetzel PM, Tanaka K and Mayer RJ (1995) Developmental changes of the 26S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J Biol Chem 270: 1850–1858 | Article | PubMed | ISI | ChemPort |
  7. Dubiel W, Ferrell K and Rechsteinier M (1993) Peptide sequence identifies MSSI, a modulator of HIV Tat-mediated transactivation as subunit 7 of the 26S protease. FEBS Lett 323: 276–278 | Article | PubMed | ISI | ChemPort |
  8. Ebisui C, Tsujinaka T, Morimoto T, Kan K, Iijma S, Yano M, Kominami E, Tanaka K and Monden M (1995) Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin Sci 89: 431–439 | PubMed | ISI | ChemPort |
  9. Eden E, Ekman L, Bennegard K, Lindmark L and Lundholm K (1984) Whole body tyrosine flux in relation to energy expenditure in weight-losing cancer patients. Metabolism 33: 1020–1027
  10. Fearon KCH, Hansell DT, Preston T, Plumb JA, Davies J, Shapiro D, Shenkin A, Calman KC and Burns HJG (1988) Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer. Cancer Res 48: 2590–2595 | PubMed | ISI | ChemPort |
  11. Fearon KCH, McMillan DC, Preston T, Winstanley FP, Cruickshank AM and Shenkin A (1991) Elevated circulating interleukin-6 is associated with an acute phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 213: 26–31 | PubMed | ISI | ChemPort |
  12. Fenteany G and Schreiber SL (1998) Lactacystin, protesome function, and cell fate. J Biol Chem 273: 8545–8548 | Article | PubMed | ISI | ChemPort |
  13. Garcia-Martinez C, Agell N, Llovera M, Lopez-Soriano FJ and Argiles JM (1993) Tumor necrosis factor-alpha increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett 323: 211–214
  14. Heber D, Chlebowski RT, Ishibashi PE, Herrold JN and Black JB (1982) Abnormalities in glucose and protein metabolism in non-cachectic lung cancer patients. Cancer Res 42: 4815–4819
  15. Kumatori A, Tanaka K, Tamura T, Fujiwara T, Ichihara A, Tokunaga F, Onikura A and Iwanaga S (1990) cDNA cloning and sequencing of component C9 of proteasomes from rat hepatoma cells. FEBS Lett 264: 279–282 | Article | PubMed | ISI | ChemPort |
  16. Lee DH and Goldberg AL (1996) Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J Biol Chem 271: 27280–27285 | Article | PubMed | ISI | ChemPort |
  17. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ and Argiles JM (1997) TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 230: 238–241 | Article | PubMed | ISI | ChemPort |
  18. Lorite MJ, Thompson MG, Drake JL, Carling G and Tisdale MJ (1998) Mechanism of muscle protein degradation induced by a cancer cachectic factor. Br J Cancer 76: 850–856
  19. Lundholm K, Bylund AC, Holm J and Schersten T (1976) Skeletal muscle metabolism in patients with malignant tumour. Eur J Cancer 12: 465–473 | Article | PubMed | ISI | ChemPort |
  20. Mansoor O, Beaufrere B, Boirie Y, Ralliere C, Taillandier D, Aurousseau E, Schoeffler P, Arnal M and Attaix D (1996) Increased mRNA for components of the lysosomal, Ca2+-activated and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc Natl Acad Sci USA 93: 2714–2718 | Article | PubMed | ChemPort |
  21. Medina R, Wing SS and Goldberg AL (1995) Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 307: 631–637 | PubMed | ISI | ChemPort |
  22. Mitch WE, Medina R, Grieber S, May RC, England BK, Price SR, Bailey JL and Goldberg AL (1994) Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 93: 2127–2133 | PubMed | ISI | ChemPort |
  23. O'Keefe SJD, Ogden J, Ramjee G and Rund J (1990) Contribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinoma. Cancer Res 50: 1226–1230 | PubMed | ChemPort |
  24. Orino E, Tanaka K, Tamura T, Sone S, Ogura T and Ichihara A (1991) ATP-dependent reversible association of proteasomes with multiple protein components to form 26S complexes that degrade ubiquitinated proteins in human HL-60 cells. FEBS Lett 284: 206–210 | Article | PubMed | ISI | ChemPort |
  25. Preston T, Fearon KCH, Robertson I, East BW and Calman KC (1987) Tissue loss during severe wasting in lung cancer patients. Vivo Body Composition Studies, Ellis KJ, Yasumara S, Morgan WD (eds). pp. 60–69, Institute of Physical Sciences: London
  26. Smith HJ, Lorite MJ and Tisdale MJ (1999) Effect of a cancer cachectic factor on protein synthesis/degradation in murine C2C12myoblasts – Modulation by eicosapentaenoic acid. Cancer Res 59: 5507–5513 | PubMed | ISI | ChemPort |
  27. St John T, Gallatin WM, Siegelman M, Smith HT, Friel VA and Weisman IL (1986) Expression cloning of a lymphocyte homing receptor cDNA: ubiquitin is the reactive species. Science 231: 845–850 | Article | PubMed | ChemPort |
  28. Temparis S, Asensi M, Taillandier D, Aurousseau E, Larbaud D, Obled A, Béchet D, Ferrara M, Estrela JM and Attaix D (1994) Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res 54: 5568–5573 | PubMed | ISI | ChemPort |
  29. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K and Tisdale M (1996a) Characterization of a cancer cachectic factor. Nature 379: 739–742 | Article | PubMed | ISI | ChemPort |
  30. Todorov PT, McDevitt TM, Cariuk P, Coles B, Deacon M and Tisdale MJ (1996b) Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res 56: 1256–1261 | PubMed | ISI | ChemPort |
  31. Voisin L, Breville D, Combaret L, Pouyet C, Taillandier D, Aurousseau E, Obled C and Attaix D (1996) Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+-activated and ubiquitin-proteasome proteolytic pathways. J Clin Invest 97: 1610–1617
  32. Windsor JA and Hill GL (1988) Risk factors for postoperative pneumonia. The importance of protein depletion. Ann Surg 298: 209–217
  33. Wing SS and Goldberg AL (1993) Glucocorticoids activate the ATP-ubiquitin-dependent proteolysis system in skeletal muscle during fasting. Am J Physiol 264: E669–E676
  34. Wing SS and Banville D (1994) 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. Am J Physiol 267: E39–E48 | PubMed | ISI | ChemPort |